Profil
Catherine Lee Kelleher worked as a Medical Director-Clinical Research at Amgen, Inc. from 2008 to 2015.
She then worked as Head-Clinical Affairs at Proteus Digital Health, Inc. from 2015 to 2016.
Prior to that, she held senior positions in clinical development at ChemoCentryx, Inc., Coherus BioSciences, Inc., and Viking Therapeutics, Inc. From 1994 to 2008, she was an Associate Professor-Medicine at The University of Colorado School of Medicine.
Kelleher holds a doctorate from UW Medicine and an undergraduate degree from The Johns Hopkins University School of Medicine.
Anciens postes connus de Catherine Lee Kelleher
| Sociétés | Poste | Fin |
|---|---|---|
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine products and therapeutic devices | Directeur Technique/Scientifique/R&D | 01/01/2016 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2015 |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2008 |
| CHEMOCENTRYX, INC. | Directeur Technique/Scientifique/R&D | - |
| COHERUS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Catherine Lee Kelleher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine products and therapeutic devices | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
UW Medicine
UW Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viking Therapeutics, Inc.
Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















